NO894218L - Beskyttede kjemiluminiscerende merkinger av f.eks. en biologisk probe. - Google Patents
Beskyttede kjemiluminiscerende merkinger av f.eks. en biologisk probe.Info
- Publication number
- NO894218L NO894218L NO89894218A NO894218A NO894218L NO 894218 L NO894218 L NO 894218L NO 89894218 A NO89894218 A NO 89894218A NO 894218 A NO894218 A NO 894218A NO 894218 L NO894218 L NO 894218L
- Authority
- NO
- Norway
- Prior art keywords
- label
- specific binding
- protected
- binding partner
- chemiluminescent
- Prior art date
Links
- 239000000523 sample Substances 0.000 title abstract description 64
- 230000001681 protective effect Effects 0.000 claims abstract description 64
- 230000009870 specific binding Effects 0.000 claims abstract description 58
- 238000000034 method Methods 0.000 claims abstract description 54
- 230000002779 inactivation Effects 0.000 claims abstract description 29
- 238000006243 chemical reaction Methods 0.000 claims abstract description 26
- 230000007062 hydrolysis Effects 0.000 claims abstract description 23
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 23
- 239000004215 Carbon black (E152) Substances 0.000 claims abstract description 11
- 229930195733 hydrocarbon Natural products 0.000 claims abstract description 11
- 150000002430 hydrocarbons Chemical class 0.000 claims abstract description 11
- 230000003647 oxidation Effects 0.000 claims abstract description 10
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 10
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract 13
- 238000002372 labelling Methods 0.000 claims description 37
- 238000003556 assay Methods 0.000 claims description 29
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 21
- -1 acridinium compound Chemical class 0.000 claims description 14
- 229910052799 carbon Inorganic materials 0.000 claims description 12
- 150000003573 thiols Chemical class 0.000 claims description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 9
- 239000012038 nucleophile Substances 0.000 claims description 9
- 238000012360 testing method Methods 0.000 claims description 9
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 8
- 150000002978 peroxides Chemical class 0.000 claims description 8
- 230000027455 binding Effects 0.000 claims description 7
- 238000010511 deprotection reaction Methods 0.000 claims description 7
- 125000003342 alkenyl group Chemical group 0.000 claims description 6
- 229910052739 hydrogen Chemical class 0.000 claims description 6
- 125000000304 alkynyl group Chemical group 0.000 claims description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 5
- VILAVOFMIJHSJA-UHFFFAOYSA-N dicarbon monoxide Chemical compound [C]=C=O VILAVOFMIJHSJA-UHFFFAOYSA-N 0.000 claims description 5
- 150000002367 halogens Chemical class 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 229910052760 oxygen Inorganic materials 0.000 claims description 5
- 239000001301 oxygen Substances 0.000 claims description 5
- 125000006239 protecting group Chemical group 0.000 claims description 5
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 125000004104 aryloxy group Chemical group 0.000 claims description 3
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 125000001424 substituent group Chemical group 0.000 claims description 3
- 125000003107 substituted aryl group Chemical group 0.000 claims description 3
- 150000001504 aryl thiols Chemical class 0.000 claims description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims 4
- 125000005843 halogen group Chemical group 0.000 claims 2
- IRRHHCACCKWUKP-UHFFFAOYSA-N C1=CC=NC=C1.[C+4] Chemical compound C1=CC=NC=C1.[C+4] IRRHHCACCKWUKP-UHFFFAOYSA-N 0.000 claims 1
- 150000001356 alkyl thiols Chemical class 0.000 claims 1
- 125000005415 substituted alkoxy group Chemical group 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 abstract description 12
- 238000010790 dilution Methods 0.000 abstract description 11
- 239000012895 dilution Substances 0.000 abstract description 11
- 108020005187 Oligonucleotide Probes Proteins 0.000 abstract description 10
- 239000002751 oligonucleotide probe Substances 0.000 abstract description 10
- 230000002441 reversible effect Effects 0.000 abstract description 9
- 239000000243 solution Substances 0.000 description 32
- RXNXLAHQOVLMIE-UHFFFAOYSA-N phenyl 10-methylacridin-10-ium-9-carboxylate Chemical compound C12=CC=CC=C2[N+](C)=C2C=CC=CC2=C1C(=O)OC1=CC=CC=C1 RXNXLAHQOVLMIE-UHFFFAOYSA-N 0.000 description 15
- 150000001875 compounds Chemical class 0.000 description 12
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical class C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 10
- 239000002773 nucleotide Substances 0.000 description 10
- 125000003729 nucleotide group Chemical group 0.000 description 10
- 239000008363 phosphate buffer Substances 0.000 description 10
- DKIDEFUBRARXTE-UHFFFAOYSA-N 3-mercaptopropanoic acid Chemical compound OC(=O)CCS DKIDEFUBRARXTE-UHFFFAOYSA-N 0.000 description 9
- 108091034117 Oligonucleotide Proteins 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 238000003860 storage Methods 0.000 description 9
- HJCUTNIGJHJGCF-UHFFFAOYSA-N 9,10-dihydroacridine Chemical class C1=CC=C2CC3=CC=CC=C3NC2=C1 HJCUTNIGJHJGCF-UHFFFAOYSA-N 0.000 description 7
- 238000009396 hybridization Methods 0.000 description 7
- BXAVKNRWVKUTLY-UHFFFAOYSA-N 4-sulfanylphenol Chemical compound OC1=CC=C(S)C=C1 BXAVKNRWVKUTLY-UHFFFAOYSA-N 0.000 description 6
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 6
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 6
- DZBUGLKDJFMEHC-UHFFFAOYSA-O acridine;hydron Chemical compound C1=CC=CC2=CC3=CC=CC=C3[NH+]=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-O 0.000 description 6
- HAXFWIACAGNFHA-UHFFFAOYSA-N aldrithiol Chemical compound C=1C=CC=NC=1SSC1=CC=CC=N1 HAXFWIACAGNFHA-UHFFFAOYSA-N 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 230000000295 complement effect Effects 0.000 description 6
- 229910017604 nitric acid Inorganic materials 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 238000011084 recovery Methods 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 239000002002 slurry Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 238000006862 quantum yield reaction Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000003298 DNA probe Substances 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 150000001251 acridines Chemical class 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 230000009918 complex formation Effects 0.000 description 3
- 239000013068 control sample Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000004020 luminiscence type Methods 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 108020003215 DNA Probes Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000005595 deprotonation Effects 0.000 description 2
- 238000010537 deprotonation reaction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- YFVGRULMIQXYNE-UHFFFAOYSA-M lithium;dodecyl sulfate Chemical compound [Li+].CCCCCCCCCCCCOS([O-])(=O)=O YFVGRULMIQXYNE-UHFFFAOYSA-M 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000000269 nucleophilic effect Effects 0.000 description 2
- AHKZTVQIVOEVFO-UHFFFAOYSA-N oxide(2-) Chemical compound [O-2] AHKZTVQIVOEVFO-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-M phenolate Chemical compound [O-]C1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-M 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 1
- NNARPPSIYMCXMB-UHFFFAOYSA-N 1,4-bis(2-methylpropoxy)-1,4-dioxobutane-2-sulfonic acid Chemical compound CC(C)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(C)C NNARPPSIYMCXMB-UHFFFAOYSA-N 0.000 description 1
- INUMMPHTUPBOEU-UHFFFAOYSA-N 1-phenylacridine Chemical compound C1=CC=CC=C1C1=CC=CC2=NC3=CC=CC=C3C=C12 INUMMPHTUPBOEU-UHFFFAOYSA-N 0.000 description 1
- 229940006193 2-mercaptoethanesulfonic acid Drugs 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- BVTJGGGYKAMDBN-UHFFFAOYSA-N Dioxetane Chemical compound C1COO1 BVTJGGGYKAMDBN-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- GHAZCVNUKKZTLG-UHFFFAOYSA-N N-ethyl-succinimide Natural products CCN1C(=O)CCC1=O GHAZCVNUKKZTLG-UHFFFAOYSA-N 0.000 description 1
- HDFGOPSGAURCEO-UHFFFAOYSA-N N-ethylmaleimide Chemical compound CCN1C(=O)C=CC1=O HDFGOPSGAURCEO-UHFFFAOYSA-N 0.000 description 1
- 208000032827 Ring chromosome 9 syndrome Diseases 0.000 description 1
- 102000003800 Selectins Human genes 0.000 description 1
- 108090000184 Selectins Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical class [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 238000013096 assay test Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 150000001638 boron Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- ZNEWHQLOPFWXOF-UHFFFAOYSA-N coenzyme M Chemical compound OS(=O)(=O)CCS ZNEWHQLOPFWXOF-UHFFFAOYSA-N 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000155 isotopic effect Effects 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- WAHQBNXSPALNEA-UHFFFAOYSA-L lithium succinate Chemical compound [Li+].[Li+].[O-]C(=O)CCC([O-])=O WAHQBNXSPALNEA-UHFFFAOYSA-L 0.000 description 1
- 229960004254 lithium succinate Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000002829 nitrogen Chemical class 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 238000005935 nucleophilic addition reaction Methods 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical group [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 125000002081 peroxide group Chemical group 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 150000003017 phosphorus Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- AAEVYOVXGOFMJO-UHFFFAOYSA-N prometryn Chemical compound CSC1=NC(NC(C)C)=NC(NC(C)C)=N1 AAEVYOVXGOFMJO-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 125000005017 substituted alkenyl group Chemical group 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Details Of Garments (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Luminescent Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/160,611 US4950613A (en) | 1988-02-26 | 1988-02-26 | Proteted chemiluminescent labels |
PCT/US1989/000722 WO1989008256A1 (en) | 1988-02-26 | 1989-02-27 | Protected chemiluminescent labels |
Publications (2)
Publication Number | Publication Date |
---|---|
NO894218D0 NO894218D0 (no) | 1989-10-24 |
NO894218L true NO894218L (no) | 1989-12-22 |
Family
ID=22577607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO89894218A NO894218L (no) | 1988-02-26 | 1989-10-24 | Beskyttede kjemiluminiscerende merkinger av f.eks. en biologisk probe. |
Country Status (15)
Country | Link |
---|---|
US (1) | US4950613A (de) |
EP (1) | EP0330433B1 (de) |
JP (1) | JPH02503268A (de) |
KR (1) | KR0132290B1 (de) |
AT (1) | ATE137021T1 (de) |
AU (1) | AU626319B2 (de) |
CA (1) | CA1333396C (de) |
DE (2) | DE68926259T2 (de) |
DK (1) | DK530489A (de) |
ES (1) | ES2012323T3 (de) |
FI (1) | FI895062A0 (de) |
GR (1) | GR900300054T1 (de) |
NO (1) | NO894218L (de) |
PT (1) | PT89834B (de) |
WO (1) | WO1989008256A1 (de) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6414152B1 (en) * | 1981-12-11 | 2002-07-02 | University Of Wales College Of Medicine Of Heath Park | Luminescent labelling material and procedures |
US5605795A (en) * | 1986-07-24 | 1997-02-25 | Tropix, Inc. | Assays using chemiluminescent, enzymatically cleavable substituted 1,2-dioxetanes and kits therefor |
US5110932A (en) * | 1986-10-06 | 1992-05-05 | Ciba Corning Diagnostics Corp. | Polysubstituted aryl acridinium esters |
US5321136A (en) * | 1987-12-31 | 1994-06-14 | London Diagnostics, Inc. | Peri substituted fused ring chemiluminescent labels and their conjugates, and assays therefrom |
US5290936A (en) * | 1987-12-31 | 1994-03-01 | London Diagnostics, Inc. | Nitro substituted chemiluminescent labels and their conjugates, and assays therefrom |
US5338847A (en) * | 1987-12-31 | 1994-08-16 | London Diagnostics, Inc. | Hydrolytically stable chemiluminescent labels and their conjugates, and assays therefrom by adduct formation |
US5227489A (en) * | 1988-08-01 | 1993-07-13 | Ciba Corning Diagnostics Corp. | Stable hydrophilic acridinium esters suitable for liposome encapsulation |
US5241070A (en) * | 1988-09-26 | 1993-08-31 | Ciba Corning Diagnostics Corp. | Nucleophilic polysubstituted aryl acridinium esters and uses thereof |
US5663074A (en) * | 1988-09-26 | 1997-09-02 | Chiron Diagnostics Corporation | Nucleophilic polysubstituted aryl acridinium ester conjugates and syntheses thereof |
US5629168A (en) * | 1992-02-10 | 1997-05-13 | British Technology Group Limited | Chemiluminescent enhancers |
WO1993020074A1 (en) * | 1992-03-27 | 1993-10-14 | Abbott Laboratories | Haptens, tracers, immunogens and antibodies for acridine-9-carboxylic acids |
US6002000A (en) * | 1992-07-20 | 1999-12-14 | Dade Behring Marburg Gmbh | Chemiluminescent compounds and methods of use |
EP0651752A1 (de) * | 1992-07-20 | 1995-05-10 | Behringwerke Ag | Chemilumineszierende derivate und methoden deren anwendung |
JP3584379B2 (ja) * | 1993-02-04 | 2004-11-04 | 持田製薬株式会社 | アクリジニウム化合物およびアクリジニウム化合物複合体 |
US5670644A (en) * | 1993-05-17 | 1997-09-23 | Lumigen, Inc. | Acridan compounds |
JPH08233820A (ja) * | 1995-02-23 | 1996-09-13 | Kdk Corp | 化学発光測定法 |
US5731148A (en) * | 1995-06-07 | 1998-03-24 | Gen-Probe Incorporated | Adduct protection assay |
ATE214697T1 (de) * | 1996-07-16 | 2002-04-15 | Nederlanden Staat | Dibenzodihydropyridincarbonsäureester und ihre anwendung in chemolumineszenz- untersuchungsverfahren |
AU7487798A (en) * | 1997-05-29 | 1998-12-30 | Bio-Rad Laboratories, Inc. | Chemiluminescent hemoglobin assay |
AU2012232986B2 (en) * | 1998-05-01 | 2014-06-12 | Gen-Probe Incorporated | System and method for incubating the contents of a reaction receptacle |
ATE423622T1 (de) | 1998-05-01 | 2009-03-15 | Gen Probe Inc | Automatisches isolierungs- und amplifizierungsverfahren für eine zielnukleinsäuresequenz |
WO2000020643A1 (en) | 1998-10-05 | 2000-04-13 | Mosaic Technologies | Reverse displacement assay for detection of nucleic acid sequences |
US6673560B1 (en) * | 1998-11-25 | 2004-01-06 | Bayer Corporation | Measurement of hydride using chemiluminescent acridinium compounds and applications thereof |
US6245519B1 (en) | 1999-02-12 | 2001-06-12 | Gen-Probe Incorporated | Protection probes |
US6127140A (en) * | 1999-06-18 | 2000-10-03 | Abbott Laboratories | Assay for quantitative measurement of analytes in biological samples |
US6723851B2 (en) * | 2001-10-31 | 2004-04-20 | Quest Diagnostics Investment Incorporated | Chemiluminescent compounds and use thereof |
CA2483694C (en) | 2002-05-17 | 2016-04-19 | Becton, Dickinson And Company | Automated system for isolating, amplifying and detecting a target nucleic acid sequence |
AU2004235747B2 (en) * | 2003-05-01 | 2009-05-28 | Gen-Probe Incorporated | Oligonucleotides comprising a molecular switch |
AU2006219332B2 (en) * | 2005-02-28 | 2010-11-11 | Eisai R & D Management Co., Ltd. | Signal amplification method |
EP1930730B1 (de) | 2005-03-10 | 2019-08-14 | Gen-Probe Incorporated | Systeme und Verfahren zur Durchführung von Tests zum Nachweis oder zur Quantifizierung von Analyten |
US7964413B2 (en) | 2005-03-10 | 2011-06-21 | Gen-Probe Incorporated | Method for continuous mode processing of multiple reaction receptacles in a real-time amplification assay |
EP2752245A3 (de) | 2010-07-23 | 2016-08-24 | Beckman Coulter, Inc. | System oder Verfahren zur Aufnahme analytischer Einheiten |
ES2844324T3 (es) | 2011-11-07 | 2021-07-21 | Beckman Coulter Inc | Brazo robótico |
KR20140092377A (ko) | 2011-11-07 | 2014-07-23 | 베크만 컬터, 인코포레이티드 | 분취기 시스템 및 작업흐름 |
BR112014011043A2 (pt) | 2011-11-07 | 2017-06-13 | Beckman Coulter Inc | detecção de recipiente de espécime |
US9910054B2 (en) | 2011-11-07 | 2018-03-06 | Beckman Coulter, Inc. | System and method for processing samples |
JP2014532881A (ja) | 2011-11-07 | 2014-12-08 | ベックマン コールター, インコーポレイテッド | 標本輸送システムのための磁気制動 |
US9482684B2 (en) | 2011-11-07 | 2016-11-01 | Beckman Coulter, Inc. | Centrifuge system and workflow |
US10427162B2 (en) | 2016-12-21 | 2019-10-01 | Quandx Inc. | Systems and methods for molecular diagnostics |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6771981A (en) * | 1979-12-19 | 1981-07-22 | Electro-Nucleonics Inc. | Chemical luminescence amplification substrate system for immuno chemistry |
US4372745A (en) * | 1979-12-19 | 1983-02-08 | Electro-Nucleonics, Inc. | Chemical luminescence amplification substrate system for immunochemistry involving microencapsulated fluorescer |
EP0082636B2 (de) * | 1981-12-11 | 2006-10-18 | The Welsh National School of Medicine | Lumineszierende Markierungssubstanzen und -verfahren |
DE3628573C2 (de) * | 1986-08-22 | 1994-10-13 | Hoechst Ag | Chemilumineszierende Acridinderivate, Verfahren zu deren Herstellung und ihre Verwendung in Lumineszenzimmunoassays |
US4745181A (en) * | 1986-10-06 | 1988-05-17 | Ciba Corning Diagnostics Corp. | Polysubstituted aryl acridinium esters |
US4927769A (en) * | 1987-07-08 | 1990-05-22 | Ciba Corning Diagnostics Corp. | Method for enhancement of chemiluminescence |
PT88562B (pt) * | 1987-09-21 | 1994-02-28 | Ml Technology Ventures | Metodo de ensaio de proteccao homogeneo para a deteccao de um analito |
NZ227506A (en) * | 1987-12-31 | 1992-06-25 | London Diagnostics Inc | Specific binding assays using chemiluminescent compounds |
-
1988
- 1988-02-26 US US07/160,611 patent/US4950613A/en not_active Expired - Lifetime
-
1989
- 1989-02-22 DE DE68926259T patent/DE68926259T2/de not_active Expired - Fee Related
- 1989-02-22 DE DE198989301679T patent/DE330433T1/de active Pending
- 1989-02-22 ES ES89301679T patent/ES2012323T3/es not_active Expired - Lifetime
- 1989-02-22 EP EP89301679A patent/EP0330433B1/de not_active Expired - Lifetime
- 1989-02-22 AT AT89301679T patent/ATE137021T1/de not_active IP Right Cessation
- 1989-02-24 PT PT89834A patent/PT89834B/pt active IP Right Grant
- 1989-02-24 CA CA000591999A patent/CA1333396C/en not_active Expired - Fee Related
- 1989-02-27 WO PCT/US1989/000722 patent/WO1989008256A1/en active Application Filing
- 1989-02-27 KR KR1019890701986A patent/KR0132290B1/ko not_active IP Right Cessation
- 1989-02-27 AU AU40723/89A patent/AU626319B2/en not_active Expired
- 1989-02-27 JP JP1503114A patent/JPH02503268A/ja active Pending
- 1989-10-24 NO NO89894218A patent/NO894218L/no unknown
- 1989-10-25 DK DK530489A patent/DK530489A/da not_active Application Discontinuation
- 1989-10-25 FI FI895062A patent/FI895062A0/fi not_active IP Right Cessation
-
1991
- 1991-07-31 GR GR90300054T patent/GR900300054T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
NO894218D0 (no) | 1989-10-24 |
JPH02503268A (ja) | 1990-10-11 |
EP0330433A3 (de) | 1991-02-27 |
ATE137021T1 (de) | 1996-05-15 |
DK530489D0 (da) | 1989-10-25 |
ES2012323T3 (es) | 1996-06-16 |
CA1333396C (en) | 1994-12-06 |
GR900300054T1 (en) | 1991-07-31 |
AU626319B2 (en) | 1992-07-30 |
WO1989008256A1 (en) | 1989-09-08 |
DE330433T1 (de) | 1990-05-03 |
DE68926259D1 (de) | 1996-05-23 |
US4950613A (en) | 1990-08-21 |
PT89834B (pt) | 1994-02-28 |
KR0132290B1 (ko) | 1998-04-11 |
EP0330433A2 (de) | 1989-08-30 |
DE68926259T2 (de) | 1996-09-19 |
FI895062A0 (fi) | 1989-10-25 |
AU4072389A (en) | 1989-09-22 |
EP0330433B1 (de) | 1996-04-17 |
ES2012323A4 (es) | 1990-03-16 |
KR900700885A (ko) | 1990-08-17 |
DK530489A (da) | 1989-12-27 |
PT89834A (pt) | 1989-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO894218L (no) | Beskyttede kjemiluminiscerende merkinger av f.eks. en biologisk probe. | |
Diamandis et al. | The biotin-(strept) avidin system: principles and applications in biotechnology | |
AU710884B2 (en) | Compositions and methods for the simultaneous detection and quantification of multiple specific nucleic acid sequences | |
JP3001906B2 (ja) | 核酸配列の増幅および検出方法 | |
US5262536A (en) | Reagents for the preparation of 5'-tagged oligonucleotides | |
JP3483829B2 (ja) | 均一保護検定用組成物 | |
US5827653A (en) | Nucleic acid detection with energy transfer | |
JPH0698039B2 (ja) | 核酸の交雑検定 | |
EP0635006A1 (de) | Europium und terbium chelatore für zeitgelöste fluorometrische teste | |
CA2058220A1 (en) | Fluorescent compound, complex, reagent, and specific binding assay employing said reagent | |
EP0210449B1 (de) | Verlängerte Chemolumineszenz | |
US6162610A (en) | Xanthan-ester and acridan substrates for horseradish peroxidase | |
JP3828150B2 (ja) | アクリダンを利用する加水分解酵素の化学発光検出 | |
JP2008136386A (ja) | ホップ潜在ウイルスの検出方法、検出用プライマーセット及び検出用キット | |
CN117106860A (zh) | 基于CRISPR/Cas的酶标探针的检测方法及应用 | |
Gillam | Non-radioactive probes for specific DNA sequences | |
EP1035214B1 (de) | Eine am 3'-Ende modifizierte Nukleinsäuresonde, geeignet zur Hybridisierung und Detektion über Fluoreszenz | |
JPS60179657A (ja) | 標識プロ−ブ及び抗−ハイブリツドを用いるハイブリツド形成分析法 | |
Alamri | Development of a series of modified acridinium esters for use in clinical diagnostics | |
JP3776229B2 (ja) | 化学発光試薬及びその製造方法 | |
CN117757986A (zh) | 基于G4 DNA酶响应的无标记CRISPR/Cas12a化学发光试剂盒及其应用 | |
US10113206B2 (en) | Methods, compositions, and kits for determining human immunodeficiency virus (HIV) | |
EP0739421A1 (de) | Hybridisierungsverfahren |